loadpatents
name:-0.013468027114868
name:-0.0051250457763672
name:-0.00066089630126953
Singh; Satyawan Patent Filings

Singh; Satyawan

Patent Applications and Registrations

Patent applications and USPTO patent grants for Singh; Satyawan.The latest application filed is for "r-(-) / s-(+)-7-[3-n substituted amino-2 hydroxypropoxy] flavones".

Company Profile
0.7.11
  • Singh; Satyawan - Lucknow IN
  • Singh; Satyawan - Uttar Pradesh IN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pharmaceutical composition for treatment of diabetes and dyslipidemia
Grant 7,959,954 - Lakshmi , et al. June 14, 2
2011-06-14
R-(-) / S-(+)-7-[3-n Substituted Amino-2 Hydroxypropoxy] Flavones
App 20110077294 - Pratap; Ram ;   et al.
2011-03-31
Herbal Medicaments For The Treatment Of Neurocerebrovascular Disorders
App 20100093870 - Ray; Madhur ;   et al.
2010-04-15
Combination kit used in the treatment of malaria
Grant 7,404,962 - Pinto , et al. July 29, 2
2008-07-29
Process for preparing guggulsterones
Grant 7,365,218 - Pratap , et al. April 29, 2
2008-04-29
Pharmaceutical composition for treatment of diabetes and dyslipidemia
App 20070178179 - Lakshmi; Vijai ;   et al.
2007-08-02
Method for the treatment of malaria by the use of primaquine derivative N.sup.1-(3-ethylidinotetrahydrofuran-2-one)-N.sup.4- (6-methoxy-8-quinolinyl)-1,4-pentanediamine as gametocytocidal agent
Grant 7,183,291 - Pratap , et al. February 27, 2
2007-02-27
Polypeptide useful as antiallergic/antiasthmatic activity, methods for the preparation thereof, pharmaceutical compositions containing such polypeptide and use thereof
App 20060160989 - Kundu; Bijoy ;   et al.
2006-07-20
Synergistic combination kit of alpha,beta-arteether, sulfadoxin and pyrimethamine for treatment of severe/multi-drug resistant cerebral malaria
App 20060141024 - Tripathi; Renu ;   et al.
2006-06-29
Herbal medicaments for the treatment of neurocerebrovascular disorders
App 20060051438 - Ray; Madhur ;   et al.
2006-03-09
Herbal medicaments for the treatment of neurocerebrovascular disorders
Grant 6,991,814 - Ray , et al. January 31, 2
2006-01-31
Method of treating a cognitive memory dysfunction using Gugulipid
Grant 6,896,901 - Pratap , et al. May 24, 2
2005-05-24
Process for preparing Guggulsterones
App 20040186306 - Pratap, Ram ;   et al.
2004-09-23
Inclusion complees of a high potent opioid peptide, pharmaceutical compositions and method of treatment
Grant 6,740,639 - Dwivedi , et al. May 25, 2
2004-05-25
Herbal medicaments for the treatment of neurocerebrovascular disorders
App 20040033277 - Ray, Madhur ;   et al.
2004-02-19
Method For The Treatment Of Malaria By The Use Of Primaquine Derivative N1-(3-ethylidinotetrahydrofuran-2-one) -n 4-(6-methoxy-8-quinolinyl)-1,4-- Pentanediamine As Gametocytocidal Agent
App 20030199697 - PRATAP, RAM ;   et al.
2003-10-23
Novel uses of Gugulipid: as cognition enhancer, anti-hyperglycemic and for dermal conditions
App 20030099729 - Pratap, Ram ;   et al.
2003-05-29
Novel uses of gugulipid: as cognition enhancer, anti-hyperglycemic and for dermal conditions
App 20020119206 - Pratap, Ram ;   et al.
2002-08-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed